Grange Capital LLC Purchases New Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Grange Capital LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 1,404 shares of the healthcare conglomerate’s stock, valued at approximately $710,000. UnitedHealth Group accounts for approximately 0.7% of Grange Capital LLC’s investment portfolio, making the stock its 28th biggest position.

Other institutional investors also recently bought and sold shares of the company. Dark Forest Capital Management LP raised its position in UnitedHealth Group by 76.9% in the second quarter. Dark Forest Capital Management LP now owns 734 shares of the healthcare conglomerate’s stock worth $374,000 after acquiring an additional 319 shares in the last quarter. Scientech Research LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at about $1,071,000. Sepio Capital LP grew its position in UnitedHealth Group by 0.3% during the second quarter. Sepio Capital LP now owns 5,822 shares of the healthcare conglomerate’s stock worth $2,965,000 after buying an additional 20 shares during the period. Texas Capital Bank Wealth Management Services Inc boosted its stake in shares of UnitedHealth Group by 6.6% during the 2nd quarter. Texas Capital Bank Wealth Management Services Inc now owns 16,134 shares of the healthcare conglomerate’s stock worth $8,216,000 after acquiring an additional 994 shares in the last quarter. Finally, Kathmere Capital Management LLC increased its stake in UnitedHealth Group by 25.1% in the 2nd quarter. Kathmere Capital Management LLC now owns 4,768 shares of the healthcare conglomerate’s stock valued at $2,428,000 after purchasing an additional 958 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the company’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.33% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of research analyst reports. TD Cowen raised their price target on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research report on Friday, October 18th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Morgan Stanley dropped their price target on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, KeyCorp reiterated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $532.26 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market cap of $489.83 billion, a price-to-earnings ratio of 34.34, a price-to-earnings-growth ratio of 1.41 and a beta of 0.62. The stock’s 50-day moving average is $541.04 and its 200-day moving average is $563.84.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the prior year, the business earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Equities analysts anticipate that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.58%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.